To realize the potential of the genome for identifying candidate drugs we must move beyond individual genes and proteins. The signalling pathways in cells provide the right level for such analyses.
This is a preview of subscription content, log in via an institution to check access.
References
Tobert, J. A. Nature Rev. Drug Discov. 2, 517–526 (2003).
Nowell, P. C. & Hungerford, D. A. Science 132, 1487–1501 (1960).
Drews, J. Science 287, 1960–1964 (2000).
Brown, D. & Superti-Furga, G. Drug Discov. Today 8, 1067–1077 (2003).
Hamosh, A. et al. Nucleic Acids Res. 30, 52–55 (2002).
Schuener, M. T., Yoon, P. W. & Khuory, M. J. Am. J. Med. Genet. 125C, 50–65 (2004).
Mabuchi, H. et al. N. Engl. J. Med. 305, 478–482 (1981).
Mabuchi, H. et al. N. Engl. J. Med. 308, 609–613 (1983).
Gerhart, J. & Kirschner, M. W. Cells, Embryos, and Evolution (Blackwell, Malden, MA, 1997).
Nüsslein-Volhard, C. & Wieschaus, E. Nature 287, 795–801 (1980).
Harris, T. E. & Lawrence, J. C. Jr Science STKE 2003, re15 (2003).
Metzstein, M. M., Stanfield, G. M. & Horvitz, H. R. Trends Genet. 10, 410–416 (1998).
Fishman, M. C. & Olson, E. N. Cell 91, 153–156 (1997).
Lee, E., Salic, A., Kruger, R., Heinrich, R. & Kirschner, M. W. PLoS Biol. 1, 116–132 (2003).
Emami, K. H. et al. Proc. Natl Acad. Sci. USA 101, 12682–12687 (2004).
Lepourcelet, M. et al. Cancer Cell 5, 91–102 (2004).
Stockwell, B. R. Nature Rev. Genet. 1, 116–125 (2000).
Giaever, G. et al. Nature Genet. 21, 278–283 (1999).
Hughes, T. R. et al. Cell 102, 109–126 (2000).
Lum, P. Y. et al. Cell 116, 121–137 (2004).
Parsons, A. B. et al. Nature Biotechnol. 22, 62–69 (2004).
Tsang, M. & Dawid, I. B. Science STKE 2004, pe17 (2004).
Ruiz i Altaba, A., Nguyen, V. & Palma, V. Curr. Opin. Genet. Dev. 13, 513–521 (2003).
Siegel, P. M. & Massagué, J. Nature Rev. Cancer 3, 807–821 (2003).
Hacohen, N., Kramer, S., Sutherland, D., Hiromi, Y. & Krasnow, M. A. Cell 92, 253–263 (1998).
Logan, C. Y. & Nusse, R. Annu. Rev. Cell Dev. Biol. 20, 781–810 (2004).
Bouwmeester, T. et al. Nature Cell Biol. 6, 97–105 (2004).
Giot, L. et al. Science 302, 1727–1736 (2003).
Mootha, V. K. et al. Nature Genet. 34, 267–273 (2003).
Berman, D. M. et al. Nature 425, 846–851 (2003).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fishman, M., Porter, J. A new grammar for drug discovery. Nature 437, 491–493 (2005). https://doi.org/10.1038/437491a
Published:
Issue Date:
DOI: https://doi.org/10.1038/437491a
- Springer Nature Limited
This article is cited by
-
Apoptosis of cancer cells is triggered by selective crosslinking and inhibition of receptor tyrosine kinases
Communications Biology (2019)
-
Targeting G protein-coupled receptor signalling by blocking G proteins
Nature Reviews Drug Discovery (2018)
-
Investigation of 7-dehydrocholesterol reductase pathway to elucidate off-target prenatal effects of pharmaceuticals: a systematic review
The Pharmacogenomics Journal (2016)
-
Late-stage C–H functionalization of complex alkaloids and drug molecules via intermolecular rhodium-carbenoid insertion
Nature Communications (2015)
-
The discovery of first-in-class drugs: origins and evolution
Nature Reviews Drug Discovery (2014)